Discover
RLYB
Rallybio Corporation
17.20
2 x 15.85
1 x 18.67
bid
ask
+
0.29
1.71%
04:00 PM
timesize
| Ytd | 213.30% | |
| 1y | 364.86% |
16.47
day range
17.20
3.20
52 week range
17.57
| Open | 16.47 | Prev Close | 16.91 | Low | 16.47 | High | 17.20 | Mkt Cap | 89.74M |
| Vol | 770.00 | Avg Vol | 247.34K | EPS | -2.93 | P/E | -5.77 | Forward P/E | -0.72 |
| Beta | -0.90 | Short Ratio | 5.26 | Inst. Own | 76.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 15.56 | 200-d Avg | 8.82 | 1yr Est | 8.25 |
| Income Statement | |||
| Total Revenue | 212.00K | ||
| Revenues (USD) | 212.00K | ||
| Gross Profit | 212.00K | ||
| Operating Expenses | 8.95M | ||
| Research and Development Expense | 2.87M | ||
| Selling, General and Administrative Expense | 6.07M | ||
| Operating Income | -8.73M | ||
| Net Income | -8.28M | ||
| Net Income Common Stock | -8.28M | ||
| Net Income Common Stock (USD) | -8.28M | ||
| Consolidated Income | -8.28M | ||
| Earnings per Basic Share | -1.46 | ||
| Earnings per Basic Share (USD) | -1.46 | ||
| Earnings per Diluted Share | -1.46 | ||
| Earning Before Interest & Taxes (EBIT) | -8.28M | ||
| Earning Before Interest & Taxes (USD) | -8.28M | ||
| Weighted Average Shares | 5.69M | ||
| Weighted Average Shares Diluted | 5.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.30M | ||
| Cash and Equivalents (USD) | 41.30M | ||
| Investments | 5.50M | ||
| Investments Current | 5.50M | ||
| Current Assets | 53.49M | ||
| Property, Plant & Equipment Net | 172.00K | ||
| Total Assets | 54.47M | ||
| Debt Current | 99.00K | ||
| Total Debt | 154.00K | ||
| Current Liabilities | 4.14M | ||
| Debt Non-Current | 55.00K | ||
| Total Liabilities | 4.20M | ||
| Accumulated Retained Earnings (Deficit) | -310.28M | ||
| Accumulated Other Comprehensive Income | 1000 | ||
| Shareholders Equity | 50.28M | ||
| Shareholders Equity (USD) | 50.28M | ||
| Assets Non-Current | 982.00K | ||
| Total Debt (USD) | 154.00K | ||
| Liabilities Non-Current | 55.00K | ||
| Trade and Non-Trade Payables | 940.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.00K | ||
| Net Cash Flow from Financing | 3.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.93M | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Net Cash Flow from Investing | 17.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.90M | ||
| Net Cash Flow from Operations | -7.98M | ||
| Share Based Compensation | 613.00K | ||